Chemo Experts, the easiest way to learn about cancer treatment
Find a Treatment:
Cancer Types

Treatment Name: Regorafenib (Stivarga®)

Regorafenib (Stivarga®) is a Chemotherapy Regimen for Colon Cancer

Thank you for visiting our Regorafenib (Stivarga®) page.

  • If you are interested in seeing the full treatment regimen page for Regorafenib (Stivarga®) sooner rather than later, please cast your vote for Regorafenib (Stivarga®).
  • Votes from users like you are important as they help us prioritize the order in which we build our content. The more requests we receive, the faster we will build it!

While we work on uploading the pages that matter to you most, we hope that links to journal article references for Regorafenib (Stivarga®) shown below will prove useful in the meantime.

Thank you for your continued support!

The ChemoExperts Team


1) Grothey A,  Van Cutsem E,  Sobrero A, et al. Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial. Lancet.  2013;381:303-312.

Created: February 16, 2019 Updated: February 16, 2019

What is Colon Cancer?

A disease of the cells from the large intestine.  Colon cancer is the third most common cancer among both men and women.  Known causes include:  family history, poor diet, sedentary lifestyle, obestity, diabetes, history of colon polyps, smoking, heavy alcohol use, prior radiation treatment to abdomen for other cancers, and old age.  The stage can vary at diagnosis and throughout treatment.  Stages of colon cancer use Tumor, Node, Metastasis (TNM) staging as well as Stage Grouping using Stages I, II, III, or IV.  The effectiveness of the treatment may depend upon the stage at diagnosis.

NOTE: Treatment Options listed below are not all-inclusive. Other treatments may be available. ChemoExperts provides drug information and does not recommend any one treatment over another. Only your Doctor can choose which therapy is appropriate for you.

Common starting doses for Regorafenib (Stivarga®)

  • Usual starting dose: 160 mg (four 40 mg tablets) by mouth once daily for 21 consecutive days followed by 7 days off